Enhertu 100mg Powder For Injection

Rx
Manufacturer AstraZeneca
  • Fast Delivery
  • Muslim-Friendly
  • FDA Approved
  • Secure Payment
Save: RM2,182.01   15% OFF
From RM516/month
  • 0% InterestNo interest on eligible instalments
  • Flexible paymentsSpread your payment across monthly instalments
  • No hidden feesClear and transparent pricing
Earn 3,000 Points on this item (Log in or register to earn upon delivery)
🎟️ Available Vouchers
ELEVEN11
RM11 OFF
Min Spend RM350.00
Valid till: 11 Nov 2026
ELEVEN7
RM7 OFF
Min Spend RM250.00
Valid till: 11 Nov 2026
ELEVEN3
RM3 OFF
Min Spend RM120.00
Valid till: 11 Nov 2026
DELIVERY5
RM5 OFF
Min Spend RM120.00

Click a voucher to copy the code. Automatically applied at checkout if conditions are met.

Prescription Required

Complete your checkout to get your prescription approved. A doctor will contact you within 30 minute(s) after payment.
Have questions? Chat with us on WhatsApp
Dr. Mohd Izzat Amir Bin Awang
Reviewed byDr. Mohd Izzat Amir Bin AwangDoctor of Medicine (MD), University of Mansoura - Manchester
Dr. Adeline Carol Peters
Written byDr. Adeline Carol PetersBachelor of Medicine and Bachelor of Surgery (MBBS) — Manipal Academy of Higher Education (MAHE)

Last updated:

Overview

Enhertu 100mg Powder For Injection contains Trastuzumab deruxtecan 100mg (powder for reconstitution) and is available as an injection. It is classified as a prescription medicine and may only be obtained with a valid prescription from a registered medical practitioner.

Only product, safety and handling information is published here. Anything beyond that is explained to you directly by your doctor or pharmacist as part of your consultation.

DoctorOnCall is a licensed online pharmacy. Orders for Enhertu 100mg Powder For Injection are processed only after a doctor has assessed your suitability and issued a prescription, and every order is checked by a registered pharmacist before it is sent out.

Directions for Use

This medicine is prepared and administered only by trained healthcare professionals as an IV infusion, with close monitoring during and after the infusion, particularly for the first dose.

Storage Instructions

Stored under controlled, refrigerated conditions by the pharmacy or hospital as specified by the manufacturer; not intended for home storage.

Side Effects

  • Nausea, vomiting, and fatigue
  • Hair loss (alopecia)
  • Low blood cell counts, including neutropenia and anaemia
  • Interstitial lung disease or pneumonitis (a boxed-warning risk – report new cough, breathlessness, or fever immediately)
  • Reduced heart pumping function (decreased left ventricular ejection fraction) – monitored with periodic heart scans

Contraindications

  • Known hypersensitivity to trastuzumab deruxtecan or any ingredient in the formulation
  • Pregnancy, due to potential serious harm to the developing baby
  • Pre-existing interstitial lung disease requiring oxygen therapy, unless specifically assessed by the oncology team

Drug / Food Interactions

  • Other medicines affecting heart or lung function require careful review by the oncology team alongside this medicine.
  • Live vaccines are generally avoided during treatment.
  • Inform your oncology team of all medicines and supplements you are taking before each cycle.

Quick Tips

  • Contact your care team immediately if you develop new or worsening cough, breathlessness, or fever, as this can signal a rare but serious lung side effect.
  • Attend all scheduled heart function scans (echocardiograms) during treatment.
  • Report any signs of infection promptly, as low blood counts can increase infection risk.
  • Discuss fertility and contraception with your oncology team before starting treatment.

Ingredients / Active Ingredients

  • Trastuzumab deruxtecan 100mg (powder for reconstitution)

Frequently Asked Questions

Product Specifications

BrandAstraZeneca
ManufacturerAstraZeneca
ClassificationPrescription medicine
Pack Size1s(Vial)
DosageDosing is calculated by the treating oncologist based on body weight and the specific cancer being treated, then given as a timed intravenous infusion every three weeks in a hospital or specialist infusion setting.
Shelf LifeRefer to the expiry date printed on the packaging; this medicine is stored and handled only by healthcare facilities.

Customer Reviews

Be the first to review this product.

Confirm Action
×

Are you sure?

×
×